Indeed, despite all the strong evidence supporting a tumor suppressive role for EPHB3 in mouse studies, Xaun et al. recently reported that EPHB3 is an independent prognostic factor for poor survival in CRC patients [11]. This evidence concerns the gene EPHB3 and neoplasm.